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TO THE EDITOR
Research and media have highlighted
carcinogenic dangers of tanning bed
exposure. Skin cancer risk of other
sources of artificial UV radiation has
been discussed, but not researched in
detail. UV nail lamps, a source of
artificial UV radiation (UVR), are
increasingly used for professional and
personal nail techniques. UV nail lamps
contain either fluorescent bulbs or light-
emitting diode lights and are used to
cure, harden, and dry nails at home and
in the salon. In 2010–2011, over 87% of
nail salons reported using a UV light
(2010–2011, Industry Statistics). Patrons
typically receive UV nail lamp services
1–4 times monthly for durations of
6–10 minutes (Schoon et al., 2010).
Such repeated exposure to UVR from
nail lamps raises concern regarding
users’ possible skin cancer risk. We
sought to better quantify the effect of
UVR emitted by UV nail lamps at nail
salons and compare their carcinogenic
potential with that of commonly used
phototherapy devices.
We elected to compare UV nail lamp
irradiance with exposure of narrowband
UVB (NBUVB) used for phototherapy, in
order to provide a perspective with
respect to a common and well-known
exposure. NBUVB is a commonly used
dermatological treatment, viewed as low
risk, although not as zero risk, for the
development of keratinocyte carcinoma
(KC, i.e., basal cell and squamous cell
carcinoma). We first measured the spec-
tral irradiance of the nail UV devices.
We then used the action spectrum for
photocarcinogenesis (Skin Cancer
Utrecht–Philadelphia human (SCUP-h))
to determine the ratio between
carcinogenic potential of the UV nail
lamp and the single NBUVB photother-
apy course.
There are over a few hundred UV nail
lamp devices on the market and we
elected to evaluate the former three
devices because of their widespread
availability in nail supply stores and
commonalities with reported wave-
lengths (365–370 nm) and wattages of
the majority of other devices. The nail
industry (Schoon et al., 2010) also
previously tested many UV nail lamps
to determine the highest UV output (by
the four 9-W and two 9-W lamps),
which they reported to represent over
90% of lamps used in salons. To mea-
sure the carcinogenic-effective irr-
adiance and wavelength produced by
three commonly used UV Nail lamp
devices, we used a Luzchem Spec-
troradiometer SPR-4001. The sensitivity
of this device covers the spectral interval
of 235–850 nm.
Three common UV Nail Lamp
devices—Device A consisted of four
9-W UV fluorescent bulbs (36 W total);
Device B consisted of one 9-W UV
fluorescent bulb (9 W); and Device C
consisted of six 1-W light-emitting diode
UV lights (6 W)—were tested.
UV nail lamps primarily emitted UVA
with no detectable UVB or UVC. The
lower limit of detection for this device is
0.1–0.2 mW m2. There was a differ-
ence in the spectral emission between
the units containing fluorescent lamps
(A and B) and the light-emitting diode
unit C. Devices A and B had peak
emission at wavelengths at 368 and
370 nm, respectively (Figure 1), whereas
Device C had a peak emission at a
wavelength of 405 nm.
Spectral irradiance in the plane of the
nails was measured from several loca-
tions within each device. Highest
recorded spectral irradiance produced
by devices A and B was 15,253 and
15,202 mW m2, respectively, whereas
Device C produced 2845 mW m2.
Devices emitted varying spectral irradi-
ance by probe location.
We used the SCUP-h action spectrum
to determine a UV nail lamp session’s
carcinogenic-effective irradiance in
terms of NBUVB phototherapy courses
(de Gruijl and Van der Leun, 1994).
SCUP-h allows the conversion of diff-
erent UV doses to the same scale of
carcinogenic effectiveness (Figure 1).
To determine each device’s carcino-
genic-effective irradiance, we calcu-
lated the sum of the product of
SCUP-h and spectral irradiance over
all wavelengths emitted by the lamp at
the probe location with highest integral
spectral irradiance.
We then converted each UV nail
lamp’s carcinogenic-effective irradiance
to a nail lamp session’s UV dose. To
calculate the nail lamp’s UV dose
(J cm2) per nail light session, we
assumed 10 minutes per UV nail lamp
session for each device’s carcinogenic-
effective irradiance.
We compared the device’s UV dose
with that of a single course of NBUVB,
by assuming a cumulative UV dose of
25 J cm2 received by a patient per
NBUVB course. A single course corre-
sponds to 15–30 treatments over a period
of 5–10 weeks (Diffey and Farr, 2007).
We then calculated the carcinogenic
equivalence in terms of NBUVB courses
(Table 1). Over 13,000 Device A or B
and more than 40,000 Device C
sessions lasting for 10 minutes would
be required to be received at the nail
plane to equal the UV dose received
during one NBUVB course. Given the
LETTERS TO EDITOR
Abbreviations: KC, keratinocyte carcinoma; NBUVB, narrowband UVB; SCUP-h, Skin Cancer Utrecht–
Philadelphia human; UVR, UV radiation
& 2013 The Society for Investigative Dermatology www.jidonline.org 1097
low theoretical risk increase from
even a course of NBUVB treatments
(Diffey and Farr, 2007), one would
need over 250 years of weekly UV
Nail sessions to experience the same
risk exposure.
Our study of three UV nail lamps
reveals that such exposure is a tiny
fraction of a single NBUVB course,
and hence does not produce a clinically
significant increased risk of developing
skin cancer. The potential associated
skin cancer risk from UV nail lamp
use has only been discussed once
in a scientific literature case series
(MacFarlane and Alonso, 2009) and
evaluated one other time by the nail
industry (Schoon et al., 2010). The case
review of two women with a history of
UV nail light exposure, who developed
squamous cell carcinomas on their
dorsal hands, concluded that exposure
to UV nail lights is a risk factor
for the development of skin cancer
(MacFarlane and Alonso, 2009). On
the basis of historical information and
comparisons between UV nail and
tanning bed lamp wattages, the authors
suggested that UV light emitted from
these nail lamps is the cause of those
lesions. However, this case review is
anecdotal and the spectral irradiance
cannot be calculated by using bulb
wattage (bulb’s power requirements)
and exposed to body surface area, but
must be measured spectroradio-
metrically, as performed in our study.
A laboratory, hired by the nail indus-
try, used an inappropriate study design
to test many UV nail lamps and con-
cluded that UV nail lamps emit low and
safe levels of UV light (Schoon et al.,
2010). Broadband meters were used
to measure UVA and UVB and then
estimate the corresponding exposure
times in sunlight in order to calculate
the UV dose received by nail lamp
users. This was incorrect, as the
spectral emission of sunlight and the
nail lamp is different, the spectral
response of the meters was not speci-
fied, and an appropriate biological end
point (e.g., erythema, burn, or skin
cancer) had not been determined
(Schoon et al., 2010).
Although some sources of UVA
and UVB contribute to the develop-
ment of KCs, UV nail lamps do not
appear to significantly increase the
lifetime risk of KC. Dermatologists
and primary-care physicians may reas-
sure patients regarding the safety of
these devices.
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Figure 1. UV nail lamp spectral power distribution by device. Note: According to the manufacturer, the
negative spectral irradiance values are due to fluctuations in electronic noise, where noise in the dark may
be slightly higher than the noise acquired during the sample measurement at a given wavelength. In that
case, if there is no signal in the given region, that value appears negative.
Table 1. NBUVB equivalents emitted by UV nail lamp device per session
UV device NBUVB A B C
Carcinogenic-effective irradiance (mW m2) — 4.7 4.9 1.6
UV dose (J cm 2)¼ (carcinogenic-effective
irradiance)  (duration)
20 3 10–4 3 10–4 9.6 10–5
Number of UV nail lamp sessions to equal one
NBUVB course
1 14,200 13,700 42,400
Abbreviation: NBUVB, narrowband UVB.
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TO THE EDITOR
Autosomal recessive oculocutaneous
albinism (OCA) is a genetic disorder
characterized by the partial or complete
loss of pigmentation in the skin, hair,
and iris (Tomita and Suzuki, 2004).
OCA is associated with a number of
vision problems and can severely affect
an individual’s quality of life (Oetting
and King, 1999; Tomita and Suzuki,
2004; Chaki et al., 2011). Many of
the molecular components that are
necessary for the development, traffick-
ing, and maintenance of melanin
pigment have been discovered by
identifying the genes for the non-
syndromic and syndromic forms of
OCA in humans. Identifying the
genetic causes of OCA, conducting
genetic testing, detecting carriers, and
improving patients’ understanding of the
implications and consequences of the
disorder through genetic counseling are
essential, especially in populations that
commonly practice inbreeding (Hussain
and Bittles, 1998). The Pakistani popula-
tion is one such example; however,
genetic information regarding OCA in
this population is limited (Jaworek et al.,
2012). To the best of our knowledge,
only one allele of OCA3 (TYRP1) and
no mutations in OCA4 (SLC45A2) have
been documented in the Pakistani
population (Forshew et al., 2005;
Jaworek et al., 2012). Here, we report
the identification of four Pakistani
albinism mutations, including three
SLC45A2 alleles and one 22-nucleo-
tide deletion in TYRP1, segregating in
four large families (Figure 1).
After obtaining institutional review
board approval and written informed
consent from all participating indivi-
duals and the parents of minor subjects,
consistent with the tenets of the
Declaration of Helsinki, we enrolled
75 large, multigeneration families segre-
gating nonsyndromic OCA (i.e., without
any other apparent clinical phenotypes)
from various regions of Pakistan (see
Supplementary Materials online) and
conducted a comprehensive molecular
analysis of TYRP1 and SLC45A2. Muta-
tions in TYRP1 rarely cause OCA, and,
to date, only nine alleles have been
detected in individuals of Southern
African, African-American, Caucasian,
Indian, or Pakistani descent (Boissy
et al., 1996; Manga et al., 1997;
Forshew et al., 2005; Rooryck et al.,
2006; Hutton and Spritz, 2008; Rooryck
et al., 2008; Chiang et al., 2009).
Mutations in TYRP1 typically result in
reddish brown or golden hair with
orange highlights (Boissy et al., 1996;
Manga et al., 1997; Forshew et al.,
2005; Rooryck et al., 2006; Hutton
and Spritz, 2008; Rooryck et al.,
2008). A sequence analysis of TYRP1
in our cohort revealed a 22-base-pair
deletion (c.647_668del) in the coding
region in family PKAB131 (Figure 1 and
Supplementary Figure S1 online). Dele-
tion of these nucleotides is predicted to
cause a frameshift in the reading frame
that will result in a truncated (p.Glu216-
GlyfsX42) TYRP1 protein (Table 1). The
affected individuals of family PKAB131
had golden hair with orange highlights,
brown eyes with foveal hypoplasia, and
nystagmus (Figure 1 and Table 1). All of
the affected individuals had white skin
at birth that gradually darkened on the
body parts exposed to sunlight, such as
the face, arms, and hands. However,
pigment deficiency was still observable
on the body parts not directly exposed
to sunlight. To date, this is the second
mutation of TYRP1 that causes an OCA3
phenotype in a family of Pakistani origin.
A sequence analysis of SLC45A2
revealed three variants that are likely to
be pathogenic in three families (Figure 1,
Table 1 and Supplementary Figure S2
online). Two missense substitutions were
identified: p.Leu84Pro (c.251T4C) and
p.Ala511Val (c.1532C4T) in families
PKAB053 and PKAB051, respectively
(Figure 1). Both missense mutationsAbbreviation: OCA, oculocutaneous albinism
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